Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 3, 2013, Pages 464-468

  Upreti, Shyam Raj ^a   Janusz, Kristen B ^b   Schluter, W William ^c   Bichha, Ram Padarath ^d   Shakya, Geeta ^e   Biggerstaff, Brad J ^b   Shrestha, Murari Man ^c   Sedai, Tika Ram ^c   Fischer, Marc ^b   Gibbons, Robert V ^f   Shrestha, Sanjaya K ^g   Hills, Susan L ^b  

^a Minister for Health and Population Nepal   (Nepal)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Kanti Children's Hospital   (Nepal)

^e National Public Health Laboratory   (Nepal)

^f ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^g Walter Reed Armed Forces Research Institute   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE;

ARTICLE; DISEASE SURVEILLANCE; HEALTH PROGRAM; HUMAN; INCIDENCE; INFECTION RISK; JAPANESE ENCEPHALITIS; MAJOR CLINICAL STUDY; NEPAL; RISK ASSESSMENT; VACCINATION; ADOLESCENT; CHILD; CLASSIFICATION; HEALTH SURVEY; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, JAPANESE; HUMANS; INFANT; JAPANESE ENCEPHALITIS VACCINES; NEPAL; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; VACCINES, ATTENUATED;

MLCS; MLOWN;

EID: 84877091465     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0196     Document Type: Article

References (20)

1. Fischer M, Lindsey N, Staples JE, Hills S, 2010. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59: 1-27.
2. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS, 2011. Estimated global incidence of Japanese encephalitis: a systematic review. Bull WorldHealthOrgan 89: 766-774.
3. World Health Organization, 2005. Global Advisory Committee on Vaccine Safety, 9-10 June 2005. Wkly Epidemiol Rec 80: 242-243.
4. Liu ZL, Hennessy S, Strom BL, Tsai TF, Wan CM, Tang SC, Xiang CF, Bilker WB, Pan XP, Yao YJ, Xu ZW, Halstead SB, 1997. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis 176: 1366-1369. (Pubitemid 27461005)
5. Yaïch M, 2009. Investing in vaccines for developing countries: how public-private partnerships can confront neglected diseases. Hum Vaccin 5: 368-369.
6. Kumar R, Tripathi P, Rizvi A, 2009. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med 360: 1465-1466.
7. Tandan JB, Ohrr H, Sohn YM, Yoksan S, Ji M, Nam CM, Halstead SB, 2007. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 25: 5041-5045. (Pubitemid 46881266)
8. Henderson A, Leake CJ, Burke DS, 1983. Japanese encephalitis in Nepal. Lancet 2: 359-360.
9. Joshi DD, 1995. Current status of Japanese encephalitis in Nepal. Southeast Asian J Trop Med Public Health 26 (Suppl 3): 34-40.
10. Pant GR, 2006. A serological survey of pigs, horses, and ducks in Nepal for evidence of infection with Japanese encephalitis virus. Ann N Y Acad Sci 1081: 124-129. (Pubitemid 44968763)
11. Bista MB, Shrestha JM, 2005. Epidemiological situation of Japanese encephalitis in Nepal. J Nep Med Assoc 44: 51-56.
12. Zimmerman MD, Scott RM, Vaughn DW, Rajbhandari S, Nisalak A, Shrestha MP, 1997. Short report: an outbreak of Japanese encephalitis in Kathmandu, Nepal. Am J Trop Med Hyg 57: 283-284. (Pubitemid 27407264)
13. Basnyat B, Zimmerman MD, Shrestha Y, Scott RM, Endy TP, 2001. Persistent Japanese encephalitis in Kathmandu: the need for immunization. J Travel Med 8: 270-271. (Pubitemid 33000608)
14. Partridge J, Ghimire P, Sedai T, Bista MB, Banerjee M, 2007. Endemic Japanese encephalitis in the Kathmandu valley, Nepal. Am J Trop Med Hyg 77: 1146-1149. (Pubitemid 351837809)
15. Bhattachan A, Amatya S, Sedai TR, Upreti SR, Partridge J, 2009. Japanese encephalitis in hill and mountain districts, Nepal. Emerg Infect Dis 15: 1691-1692.
16. Wierzba TF, Ghimire P, Malla S, Banerjee MK, Shrestha S, Khanal B, Sedai TR, Gibbons RV, 2008. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy. Am J Trop Med Hyg 78: 1002-1006. (Pubitemid 351967823)
17. Burke DS, Nisalak A, 1982. Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol 15: 353-361. (Pubitemid 12178864)
18. World Health Organization, 2008. WHO-Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases. Report No: WHO/V&B/03.01. Available at: http://whqlibdoc.who.int/hq/2003/WHO-V&B- 03.01.pdf. Accessed June 2, 2011.
19. Andrus JK, Banerjee K, Hull BP, Smith JC, Mochny I, 1997. Polio eradication in the World Health Organization South-East Asia Region by the year 2000: midway assessment of progress and future challenges. J Infect Dis 175 (Suppl 1): S89-S96. (Pubitemid 27053492)
20. World Health Organization Regional Office for South-East Asia, 2011. Malaria Situation in SEAR Countries: Nepal. Available at: http://www.searo.who. int/EN/Section10/Section21/Section340.htm. Accessed February 15, 2011.